175 related articles for article (PubMed ID: 32429421)
1. Broussoflavonol B from
Jeong JH; Ryu JH
Molecules; 2020 May; 25(10):. PubMed ID: 32429421
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.
Wang L; Zhao Y; Wu Q; Guan Y; Wu X
Mol Med Rep; 2018 Mar; 17(3):4299-4306. PubMed ID: 29363722
[TBL] [Abstract][Full Text] [Related]
3. Anti-Cancer Potential of
An EJ; Kim Y; Lee SH; Ko HM; Chung WS; Jang HJ
Molecules; 2020 May; 25(10):. PubMed ID: 32422890
[TBL] [Abstract][Full Text] [Related]
4. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
5. Momordica cochinchinensis Spreng. seed extract suppresses breast cancer growth by inducing cell cycle arrest and apoptosis.
Zheng L; Zhang Y; Liu Y; Yang XO; Zhan Y
Mol Med Rep; 2015 Oct; 12(4):6300-10. PubMed ID: 26252798
[TBL] [Abstract][Full Text] [Related]
6. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.
Liu X; Cai W; Niu M; Chong Y; Liu H; Hu W; Wang D; Gao S; Shi Q; Hu J; Zhou X; Yu R
J Neurooncol; 2015 Feb; 121(3):469-77. PubMed ID: 25528634
[TBL] [Abstract][Full Text] [Related]
7. Dihydrosanguinarine suppresses pancreatic cancer cells via regulation of mut-p53/WT-p53 and the Ras/Raf/Mek/Erk pathway.
Wu SZ; Xu HC; Wu XL; Liu P; Shi YC; Pang P; Deng L; Zhou GX; Chen XY
Phytomedicine; 2019 Jun; 59():152895. PubMed ID: 30913453
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
11. A novel anticancer agent Broussoflavonol B downregulates estrogen receptor (ER)-α36 expression and inhibits growth of ER-negative breast cancer MDA-MB-231 cells.
Guo M; Wang M; Deng H; Zhang X; Wang ZY
Eur J Pharmacol; 2013 Aug; 714(1-3):56-64. PubMed ID: 23769740
[TBL] [Abstract][Full Text] [Related]
12. Broussoflavonol B restricts growth of ER-negative breast cancer stem-like cells.
Guo M; Wang M; Zhang X; Deng H; Wang ZY
Anticancer Res; 2013 May; 33(5):1873-9. PubMed ID: 23645733
[TBL] [Abstract][Full Text] [Related]
13. Magnolol induces apoptosis in osteosarcoma cells via G0/G1 phase arrest and p53-mediated mitochondrial pathway.
Zhou S; Wen H; Li H
J Cell Biochem; 2019 Oct; 120(10):17067-17079. PubMed ID: 31155771
[TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin inhibits cell growth and induces cell cycle arrest through inhibition of FoxM1 in colorectal cancer cells.
Yue M; Li S; Yan G; Li C; Kang Z
Cell Cycle; 2018; 17(2):240-249. PubMed ID: 29301438
[TBL] [Abstract][Full Text] [Related]
15. FOXM1 allows human keratinocytes to bypass the oncogene-induced differentiation checkpoint in response to gain of MYC or loss of p53.
Molinuevo R; Freije A; de Pedro I; Stoll SW; Elder JT; Gandarillas A
Oncogene; 2017 Feb; 36(7):956-965. PubMed ID: 27452522
[TBL] [Abstract][Full Text] [Related]
16. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1.
Cınar V; Hamurcu Z; Guler A; Nurdinov N; Ozpolat B
Breast Cancer; 2022 Nov; 29(6):1106-1120. PubMed ID: 36006564
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
19. Diarylheptanoids suppress proliferation of pancreatic cancer PANC-1 cells through modulating shh-Gli-FoxM1 pathway.
Dong GZ; Jeong JH; Lee YI; Lee SY; Zhao HY; Jeon R; Lee HJ; Ryu JH
Arch Pharm Res; 2017 Apr; 40(4):509-517. PubMed ID: 28258481
[TBL] [Abstract][Full Text] [Related]
20. Aberrant activation of ERK/FOXM1 signaling cascade triggers the cell migration/invasion in ovarian cancer cells.
Lok GT; Chan DW; Liu VW; Hui WW; Leung TH; Yao KM; Ngan HY
PLoS One; 2011; 6(8):e23790. PubMed ID: 21858223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]